These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26774536)

  • 21. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease.
    Caviness JN; Hentz JG; Evidente VG; Driver-Dunckley E; Samanta J; Mahant P; Connor DJ; Sabbagh MN; Shill HA; Adler CH
    Parkinsonism Relat Disord; 2007 Aug; 13(6):348-54. PubMed ID: 17347022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.
    Kulisevsky J; Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Campolongo A; García-Sánchez C; Pascual-Sedano B; Ribosa-Nogué R; Villa-Bonomo C
    Parkinsonism Relat Disord; 2013 Sep; 19(9):812-7. PubMed ID: 23773412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing Cognitive Impairment in Parkinson's Disease.
    Bailey M; Goldman JG
    Semin Neurol; 2017 Apr; 37(2):167-175. PubMed ID: 28511257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease.
    Macaskill MR; Graham CF; Pitcher TL; Myall DJ; Livingston L; van Stockum S; Dalrymple-Alford JC; Anderson TJ
    Neuropsychologia; 2012 Dec; 50(14):3338-47. PubMed ID: 23000134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
    Vasconcellos LF; Pereira JS
    J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
    Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild cognitive impairment in Parkinson's disease.
    Aarsland D; Brønnick K; Fladby T
    Curr Neurol Neurosci Rep; 2011 Aug; 11(4):371-8. PubMed ID: 21487730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Clinical Features with Plasma and Multi-modal Neuroimaging Biomarkers to Diagnose Mild Cognitive Impairment in Early Drug-Naive Parkinson's Disease.
    Wang Y; Ning H; Ren J; Pan C; Yu M; Xue C; Wang X; Zhou G; Chen Y; Liu W
    ACS Chem Neurosci; 2022 Dec; 13(23):3523-3533. PubMed ID: 36417458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
    Estanga A; Rodriguez-Oroz MC; Ruiz-Martinez J; Barandiaran M; Gorostidi A; Bergareche A; Mondragon E; Lopez de Munain A; Marti-Masso JF
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1097-100. PubMed ID: 25127457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
    Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Kulisevsky J
    Neurobiol Dis; 2012 Jun; 46(3):590-6. PubMed ID: 22484304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.